Novavax Shares Fall After Q3 Beat and Higher 2026 Outlook

John Kim

1 min read

Add as a preferred source on Google

Novavax Shares Fall After Q3 Beat and Higher 2026 Outlook

Higher product sales helped quarterly results top expectations. Novavax also revised its profitability expectations.

By John Kim

Published Nov 6, 2026, 3:41 PM EST

An unmarked vaccine vial rests on a stainless-steel laboratory bench / TokenPost.ai

Novavax (NVAX) shares fell Thursday, Nov. 5, after the company posted better-than-expected third-quarter 2026 results and raised its 2026 outlook.

Higher product sales helped lift the quarterly results above expectations. Novavax also revised its profitability expectations alongside the higher full-year outlook.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.